article_snippet: Pharmaceutical firm Biogen, which developed New Alzheimer's drug, called aduncanumab, wants to recruit at least 1,000 patients for tests by the end of the year.
highlights_snippet: Pharmaceutical firm wants to recruit 1,000 patients for tests by end of 2015 .